Use access key #2 to skip to page content.
$12.50 2.00 (19.05%)
10/10/2008 4:00 PM

Amicus Therapeutics, Inc. (FOLD)

CAPS Rating:
*

A clinical-stage biopharmaceutical company, which focused on the discovery, development and commercialization of novel small molecule, orally-administered drugs, known as pharmacological chaperones, for the treatment of a range of human genetic diseases.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating FOLD

Add Stock to Watchlist

What the Community Thinks

Total Members

20 Outperforms
11 Underperforms
 

All-Stars

3 Outperforms
6 Underperforms
 

Wall Street

4 Outperforms
0 Underperforms
 

Members bullish on FOLD are also bullish on:

Members bearish on FOLD are also bearish on:

Ticker Tags

IPO in 2007 (239), Micro Cap (4824), Biotechnology (295), It's a Noun! (83), It's a Verb! (47)
Suggest a tag

Amicus Therapeutics, Inc. At A Glance

Current Price: $12.50
Last Trade Time: 10/10/2008 4:00 PM
Open: $10.05
Previous Close: $10.50
Daily Range: $9.75 - $12.92
52-Week Range: $9.00 - $18.22
Volume: 25,420
Market Cap: $236.76M
P/E Ratio: 11.67
Compare Our Special Broker Offers!

Stock Trends

FOLD VS S&P 500 (SPY)

FOLD 12 month chart vs. S&P

News & Discussion Boards

Sorry no news articles available for FOLD.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 8 :   1 2 Next »

Recs

0

 (FOLD)

Avatar zackmax (88.86) Submitted: 9/30/08 6:02 AM : Outperform Start Price: $17.08 FOLD Score: -4.62

ccest

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (FOLD)

Avatar mjan706 (< 20) Submitted: 9/22/08 1:48 AM : Outperform Start Price: $15.21 FOLD Score: 11.07

An Icahn portfolio stock.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (FOLD)

Avatar MikeDubs (78.24) Submitted: 8/14/08 7:03 PM : Underperform Start Price: $17.30 FOLD Score: -4.15

Short interest is high and recent run-up in price is unwarranted. I see a floor at $11 a share to buy back in.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (FOLD)

Avatar zzlangerhans (98.66) Submitted: 7/15/08 12:20 AM : Underperform Start Price: $12.43 FOLD Score: -27.90

Amicus is now trading above its recent range without substantial progress in the pipeline. Phase II data for Amigal and Plicera was not particularly compelling, and phase III trials will not be initiated this year. It's kind of a mystery why the share price is floating upward despite the drag on the rest of small cap biotech, but it seems to be well into overvalued territory at this point.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (FOLD)

Avatar WordTickers (< 20) Submitted: 5/31/08 12:19 PM : Outperform Start Price: $9.91 FOLD Score: 60.84

Testing out a portfolio with outperforms on stocks with tickers that spell words.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 8 :   1 2 Next »

Wall Street

Results 1 - 4 of 4  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackIcahn 67.53 12/31/07 Outperform NS $10.75+16.28%-39.47%+55.75 Toggle the visibility of 60-Second Pitch and replies
TrackPacificGrow 57.28 07/10/07 Outperform NS $12.88-2.95%-41.93%+38.98
TrackLazardCapit < 20 07/10/07 Outperform NS $12.70-1.57%-41.88%+40.30
TrackJPMorgan 21.18 07/10/07 Outperform NS $13.00-3.85%-41.89%+38.04

Results 1 - 4 of 4  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners